Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2016; 37(01): 4-5
DOI: 10.4103/0971-5851.176980
REVIEW ARTICLE

Prostate cancer is not breast cancer

Ajit Venniyoor
Department of Medical Oncology, National Oncology Center, The Royal Hospital, Muscat, Sultanate of Oman
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Cancers of the prostate and breast are hormone dependent cancers. There is a tendency to equate them and apply same algorithms for treatment. It is pointed out that metastatic prostate cancer with bone-only disease is a potentially fatal condition with a much poorer prognosis than metastatic breast cancer and needs a more aggressive approach.

Keywords

Bone-only disease - metastatic prostate cancer - prognosis


Publication History

Article published online:
12 July 2021

© 2016. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, et al. ESO-ESMO 2 nd international consensus guidelines for advanced breast cancer (ABC2). Breast 2014;23:489-502.
  • 2 Valkenburg KC, Steensma MR, Williams BO, Zhong Z. Skeletal metastasis: Treatments, mouse models, and the Wnt signaling. Chin J Cancer 2013;32:380-96.
  • 3 Nørgaard M, Jensen AØ, Jacobsen JB, Cetin K, Fryzek JP, Sørensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: A population based cohort study in Denmark (1999 to 2007). J Urol 2010;184:162-7.
  • 4 Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark. BMC Cancer 2011;11:29.
  • 5 Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61-6.
  • 6 Pezaro CJ, Omlin A, Lorente D, Nava Rodrigues D, Ferraldeschi R, Bianchini D, et al. Visceral disease in castration-resistant prostate cancer. Eur Urol 2014;65:270-3.
  • 7 Parker C, Nilsson S, Heinrich D, Helle SI, O′Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 2013;369:213-23.
  • 8 Presented at ESMO; 2014. Available from: http://www.oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Chemohormonal-therapy-versus-hormonal-therapy-for-hormone-naive-high-volume-newly-metastatic-prostate-cancer-PrCa-ECOG-led-phase-III-randomized-trial. [Last accessed on 2014 Dec 12].
  • 9 Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, et al. Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): A randomised, open-label, phase 3 trial. Lancet Oncol 2013; 14:149-58.